为更好与投资者进行交流，公司将向投资者提前征集问题。投资 者可于 2023 年 05 月 09 日前访问网址 https://eseb.cn/13Tkpsz0tj2 或 使用微信扫描下方小程序码进行会前提问，公司将通过本次业绩说明 会，在信息披露允许范围内就投资者普遍关注的问题进行回答。 证券代码：002810 证券简称：山东赫达 公告编号：2023-048 山东赫达集团股份有限公司 关于举行 2022 年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整， 没有虚假记载、误导性陈述或重大遗漏。 山东赫达集团股份有限公司（以下简称"公司"）2022 年度报告 已于 2023 年 4 月 26 日公布，为了让广大投资者能进一步了解公司 2022 年年度报告和经营情况，公司将于 2023 年 5 月 9 日（星期二） 15:00-17:00 在"价值在线"举办 2022 年度业绩说明会。本次年度业 绩说明会将采用网络互动方式举行，投资者可通过"价值在线" （www.ir-online.cn）平台参与本次业绩说明会。 参与方式一：访问网址 https://eseb.cn/13Tkpsz0t ...

证券代码：002810 证券简称：山东赫达 山东赫达股份有限公司投资者关系活动记录表 编号：【2016-001】 | --- | --- | --- | --- | |------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

证券代码：002810 证券简称：山东赫达 山东赫达股份有限公司投资者关系活动记录表 编号：【2016-002】 | --- | --- | --- | --- | --- | |-------------------|---------------------|---------------------------------------------------------------|---------------------------------------------------------------------------------------------------|----------| | | | | 特定对象调研 □分析师会议 □媒体采访 □ | | | 投资者关系活 | | | 业绩说明会 □新闻发布会 □路演活动 | | | 动类别 | □ | 现场参观 □一对一沟通 | | | | | □ | 其他（请文字说明其他活动内容） | | | | | | 招商证券研究发展中心 周铮、于庭泽 西南证券研究发展中心 张汪强 | | | | | | 嘉实基金研究部 苏文杰 | | | | | ...

证券代码：002810 证券简称：山东赫达 山东赫达股份有限公司投资者关系活动记录表 编号：【2016-003】 | --- | --- | --- | --- | |---------------------------|-------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------| | | | 特定对象调研 □分析师 ...

证券代码：002810 证券简称：山东赫达 山东赫达股份有限公司投资者关系活动记录表 编号：【2019-001】 | --- | --- | --- | --- | --- | --- | --- | |---------------------------|-----------------------------------------------------------|-------|----------------------------------------------------|--------|-------|-------| | 投资者关系活 \n动类别 | 业绩说明会 □新闻发布会 □路演活动 \n□ 现场参观 □一对一沟通 | | 特定对象调研 □分析师会议 □媒体采访 □ | | | | | | □ 其他（请文字说明其他活动内容） | | | | | | | 参与单位名称 及人员姓名 | 安信证券研究中心 张汪强（高级分析师） | | | | | | | 时间 | 2019 年 1 月 17 日星期四 | | | | | | | 地点 | 公司会议室 | | | | | | | 上 ...

证券代码：002810 证券简称：山东赫达 山东赫达股份有限公司投资者关系活动记录表 编号：【2019-002】 | --- | --- | --- | --- | --- | --- | |-------------------------|--------------------------------------------------------------------------------------|----------------------------------------------------|-------|-------|-------| | | | 特定对象调研 □分析师会议 □媒体采访 □业 | | | | | 投资者关系活 动类别 | □ 现场参观 □一对一沟通 □ 其他（请文字说明其他活动内容） 中信建投证券 研究发展部 郑勇 | 绩说明会 □新闻发布会 □路演活动 | | | | | 参与单位名称 及人员姓名 | 华商基金 研究发展部 安迪 | 中国人寿养老保险股份有限公司 投资中心研究部 汪欢吉 | | | | | | 华泰证券 研究所 庄汀洲 中泰证券 研究所 张倩 ...

证券代码：002810 股票简称：山东赫达 公告编号：2022-053 山东赫达集团股份有限公司 关于参加山东辖区上市公司 2022 年度 投资者网上集体接待日的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整， 没有虚假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，便于广大投资者更加深入、 全面地了解公司经营发展等情况，提升公司投资者关系管理水平，保 护投资者利益，山东赫达集团股份有限公司（以下简称"公司"） 将参 加"山东辖区上市公司 2022 年度投资者网上集体接待日"活动，现 将有关事项公告如下： 本次投资者网上集体接待日活动将通过全景路演平台线上交流， 投资者可以登录全景网"投资者关系互动平台"（http://ir.p5w.net/） 参与本次投资者网上接待日活动，互动交流时间为 2022 年 11 月 16 日（星期三）下午 14:00-16:00。 公司董事会秘书毕松羚先生、财务总监崔玲女士将通过网络在线 形式与投资者进行沟通交流，欢迎广大投资者积极参与。 特此公告。 山东赫达集团股份有限公司董事会 二零二二年十一月十一日 ...

Financial Performance - The company's revenue for Q3 2022 was ¥424,712,600.11, representing a year-over-year increase of 1.54%[7] - Net profit attributable to shareholders for Q3 2022 was ¥80,521,942.88, a decrease of 11.38% compared to the same period last year[7] - The net profit after deducting non-recurring gains and losses was ¥78,145,529.78, down 10.34% year-over-year[7] - Total revenue for the period reached ¥1,332,097,422.00, an increase of approximately 13.76% compared to ¥1,171,018,900.93 in the previous period[33] - The net profit attributable to the parent company's shareholders was CNY 305,848,091.96, compared to CNY 276,650,526.18 in the previous period, reflecting an increase of about 10.6%[36] - Basic earnings per share for the current period were CNY 0.90, up from CNY 0.82 in the previous period, indicating a growth of 9.8%[39] Assets and Liabilities - The total assets at the end of Q3 2022 reached ¥3,125,702,850.29, an increase of 18.60% from the end of the previous year[7] - The total assets increased to ¥3,125,702,850.29, compared to ¥2,635,527,092.73, marking a growth of approximately 18.63%[32] - Non-current assets totaled ¥2,232,322,012.98, up from ¥1,825,268,587.97, representing an increase of about 22.29%[32] - Current liabilities rose to ¥905,714,258.56 from ¥842,181,646.18, reflecting an increase of approximately 7.99%[32] - The company's equity attributable to shareholders reached ¥1,826,134,726.06, compared to ¥1,548,237,528.78, an increase of about 18.00%[32] Cash Flow - Cash flow from operating activities for the year-to-date was ¥220,426,390.54, down 44.56% year-over-year[7] - The net cash flow from operating activities was CNY 220,426,390.54, a decrease from CNY 397,593,896.89 in the previous period, showing a decline of approximately 44.6%[40] - Cash and cash equivalents at the end of the period totaled CNY 149,321,797.42, down from CNY 178,301,360.69 at the end of the previous period, a decrease of about 16.3%[42] - The company reported a net cash outflow from investing activities of CNY -425,224,065.41, compared to CNY -398,204,110.37 in the previous period, indicating an increase in cash outflow[42] - The net cash flow from financing activities was CNY 248,495,134.66, a significant improvement from CNY -11,258,866.38 in the previous period[42] Expenses and Investments - Management expenses increased by 63.44% to ¥87,638,976.05, primarily due to repair-related costs and increased personnel expenses[16] - The company experienced a 640.71% increase in investment income, totaling ¥34,539,129.11, attributed to higher returns from joint ventures[16] - The company reported a decrease in cash received from investment income, which fell to CNY 643,343.40, down 86.65% from CNY 4,817,478.88 in the previous year[19] - The company distributed dividends totaling CNY 49,364,291.01, a significant increase of 776.71% compared to CNY 5,630,649.60 from the previous year[19] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 32,406, with the largest shareholder, Bi Xinde, holding 26.76% of the shares[20] Future Outlook - Future outlook includes continued focus on market expansion and potential new product development to sustain growth momentum[33]

Financial Performance - The company's operating revenue for the first half of 2022 was ¥907,384,821.89, representing a 20.54% increase compared to ¥752,762,204.93 in the same period last year[29]. - Net profit attributable to shareholders of the listed company reached ¥225,326,149.08, up 21.28% from ¥185,790,873.08 in the previous year[29]. - The net profit after deducting non-recurring gains and losses was ¥223,644,017.69, reflecting a 26.03% increase from ¥177,456,099.78 year-on-year[29]. - The basic earnings per share increased to ¥0.66, a 20.00% rise compared to ¥0.55 in the same period last year[29]. - The gross profit margin for the main business income was 37.41%, slightly down by 1.25% from the previous year[87]. - Export revenue amounted to ¥564,440,378.39, accounting for 62.21% of total revenue, with a year-on-year growth of 34.93%[87]. - The company achieved a significant increase in trade product sales, with revenue rising by 44.83% year-on-year[87]. - The company invested ¥37,914,560.93 in R&D, which is a 14.65% increase from ¥33,068,715.32 in the previous year[84]. - The management expenses increased by 65.54% to ¥54,237,881.67, primarily due to maintenance costs and increased personnel expenses related to the pandemic[84]. - The company reported a significant increase in financing activities, with net cash flow from financing activities rising by 578.28% to ¥227,030,763.39[84]. Assets and Liabilities - The total assets of the company at the end of the reporting period were ¥3,096,982,100.91, which is a 17.51% increase from ¥2,635,527,092.73 at the end of the previous year[29]. - The net assets attributable to shareholders of the listed company were ¥1,779,166,962.02, up 14.92% from ¥1,548,237,528.78 at the end of the previous year[29]. - The net cash flow from operating activities was ¥123,772,622.19, a decrease of 54.33% compared to ¥271,018,678.53 in the same period last year[29]. - Total assets at the end of the reporting period amounted to 3,090,000,000.00 CNY, with cash and cash equivalents accounting for 4.96% of total assets, down from 6.29% in the previous year[90]. - Accounts receivable increased to 465,408,645.61 CNY, representing 15.03% of total assets, up from 11.31% year-over-year, indicating a 3.72% increase in proportion[90]. - Inventory stood at 240,476,544.43 CNY, which is 7.76% of total assets, slightly down from 8.80% in the previous year, reflecting a decrease of 1.04%[90]. - Long-term borrowings rose to 307,256,776.97 CNY, representing 9.92% of total liabilities, an increase of 3.00% from the previous year[90]. - The construction in progress increased to 1,015,052,387.13 CNY, accounting for 32.78% of total assets, up from 26.32% year-over-year, indicating a growth of 6.46%[90]. Market and Industry Insights - The company specializes in the research, production, and sales of water-soluble polymers, primarily non-ionic cellulose ethers and plant capsules, establishing itself as a leader in the cellulose ether industry[39]. - The demand for construction-grade cellulose ether is driven by the growth of the construction industry in China, with increasing investment scale and housing renovation areas[50]. - The promotion of premixed mortar by policies is expected to boost the demand for construction-grade cellulose ether due to its advantages in quality stability and environmental friendliness[52]. - The market for pharmaceutical-grade cellulose ether is expanding, particularly for controlled-release formulations, which are technically challenging and have high added value[48]. - The company’s cellulose ether products are utilized in various applications, including construction, pharmaceuticals, and food, highlighting their versatility[50]. - The cellulose ether market is influenced by urbanization trends and consumer upgrades, which are expected to drive future demand[50]. - The company has extended its product line to include chemical equipment and other chemical products, diversifying its business operations[39]. Research and Development - The company has invested in advanced cellulose ether production equipment, achieving full-process automation and smart manufacturing[39]. - The company has received recognition for its technological innovations, including a national invention patent for controlled-release cellulose ether[39]. - The company is focusing on developing specialized cellulose ethers for controlled-release formulations, which is crucial for upgrading China's pharmaceutical industry and ensuring public health[53]. - The company’s new product development includes a patented controlled-release HPMC, filling a domestic market gap and enhancing its product portfolio[73]. Risk Management - The company faces various risks including market competition, raw material price fluctuations, and international trade risks[6]. - The company emphasizes the risk of market competition affecting its main products, cellulose ether and plant capsules, which could lead to decreased profitability if market conditions change unfavorably[117]. - The company faces raw material price fluctuation risks, particularly for refined cotton and basic chemical raw materials, which could impact gross margins[118]. - Environmental protection risks are highlighted, with potential increased costs due to stricter regulations and the need for compliance with environmental standards[119]. - The company has implemented internal control measures for its forward foreign exchange business to mitigate risks associated with exchange rate fluctuations[110]. Environmental Compliance - The company has implemented advanced wastewater treatment technologies, significantly reducing wastewater discharge and resource usage[144]. - The company has completed the construction of a new wastewater treatment facility, which is currently in the commissioning phase[144]. - The company has received environmental impact approvals for multiple projects, including a 20,000 tons/year cellulose ether project[145]. - The company has engaged third-party testing firms to monitor environmental compliance as per regulatory requirements[150]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[150]. Corporate Governance and Social Responsibility - The company emphasizes the protection of shareholder and creditor rights, ensuring fair treatment and timely information disclosure to all investors[151]. - The company has established a robust internal control system and an interactive platform for investor communication[151]. - The company actively engages in community support, contributing to local education, culture, and health initiatives[154]. - The company reported a total donation of 1 million yuan for various social welfare activities during the reporting period[154]. - The company has implemented various employee welfare measures to create a comfortable working environment and retain talent[152].

Revenue and Profit - Revenue for Q1 2022 was CNY 391,849,249.22, an increase of 19.05% compared to CNY 329,138,210.19 in the same period last year[3] - Net profit attributable to shareholders was CNY 96,333,422.50, reflecting a growth of 20.66% from CNY 79,839,112.59 year-on-year[3] - Operating profit reached CNY 111,483,646.31, up from CNY 93,225,802.92, reflecting a growth of 19.5%[33] - Net profit attributable to the parent company was CNY 96,333,422.50, compared to CNY 79,839,112.59, representing a year-over-year increase of 20.6%[36] - The basic earnings per share improved to CNY 0.2822 from CNY 0.2370, an increase of 19.0%[36] Cash Flow - Net cash flow from operating activities decreased by 80.74% to CNY 15,864,255.81, down from CNY 82,389,348.13 in the previous year[3] - Cash inflow from operating activities totaled ¥368,847,483.24, an increase of 11.3% from ¥331,235,772.37 in the previous period[40] - Cash outflow from operating activities increased to ¥352,983,227.43, up 41.9% from ¥248,846,424.24 in the previous period[40] - The net cash flow from investing activities is -¥190,320,925.54, worsening from -¥93,238,028.70 in the previous period[40] - Cash inflow from financing activities reached ¥206,174,744.96, significantly up from ¥16,116,337.26 in the previous period[40] - The net cash flow from financing activities improved to ¥179,884,941.79, compared to -¥51,720,709.13 in the previous period[40] - The ending balance of cash and cash equivalents is ¥104,064,015.91, down from ¥128,805,665.42 in the previous period[40] Assets and Liabilities - Total assets increased by 5.16% to CNY 2,771,411,883.76 from CNY 2,635,527,092.73 at the end of the previous year[5] - The total liabilities increased to CNY 1,124,286,605.90 from CNY 1,087,289,563.95, marking a rise of 3.4%[29] - Non-current liabilities rose significantly to CNY 358,182,855.16 from CNY 245,107,917.77, an increase of 46.1%[29] - The company's total equity increased to CNY 1,647,125,277.86 from CNY 1,548,237,528.78, reflecting a growth of 6.4%[29] - The company's total current assets at the end of the reporting period were ¥804,677,288.94, slightly down from ¥810,258,504.76 at the beginning of the year[20] - The total non-current assets increased to ¥1,966,734,594.82 from ¥1,825,268,587.97, indicating growth in long-term investments[23] Shareholder Information - The total number of common shareholders at the end of the reporting period was 10,274, with the top ten shareholders holding significant stakes[16] - The largest shareholder, Bi Xinde, holds 26.76% of the shares, amounting to 91,670,305 shares[16] Expenses - Management expenses surged by 93.27% to CNY 29,959,650.60, compared to CNY 15,501,081.70 in the same period last year[11] - Research and development expenses for the quarter were CNY 18,137,161.74, up from CNY 14,577,110.46, indicating a 24.0% increase[30] Investment Income - Investment income increased significantly by 857.12% to CNY 21,783,889.72 from CNY 2,275,975.68 year-on-year[11] - The company received cash from investment income amounting to ¥483,461.96 during the current period[40] Borrowings - Long-term borrowings increased by 64.53% to CNY 299,996,776.97, up from CNY 182,333,256.30[10] - Short-term borrowings increased to ¥229,149,554.71 from ¥194,984,118.30, reflecting a rise in financing needs[23] - Cash obtained from borrowings surged by 1520.69% to CNY 162,068,675.38 from CNY 10,000,000.00 in the same period last year[12] Cash Distribution - Cash distributed for dividends, profits, or interest payments increased by 128.80% to ¥4,113,702.89, mainly due to an increase in loan interest payments[15] - Cash used for debt repayment decreased by 80.66% to ¥10,000,000.00, primarily due to a reduction in loan repayments[15]